Sight Sciences Beats Q3, Raises FY26 Revenue Guidance to $92M-$93M
SGHT has more than doubled off its 52-week low of $3.378 on elevated volume (2.2× avg).
Summary
Sight Sciences beat Q3 revenue estimates with $24.9M (+25%) and raised full-year 2026 revenue guidance to $92M-$93M, driven by a fast-scaling dry-eye business and sharply lower cash burn.
Key Events · Earnings and Guidance · SGHT
-
Q3 Revenue Beats, Up 25%
Revenue came in at $24.9M versus $19.9M a year ago, ahead of the $23.5M consensus estimate.
-
FY26 Guidance Raised
Full-year 2026 revenue guidance was lifted to $92M-$93M (19%-20% growth) from $88M-$92M; IDE guidance rose to ~$12M from $9M-$11M.
-
Dry Eye Scales Rapidly
Interventional Dry Eye revenue reached $3.9M versus $0.2M a year ago, with gross margin up to 79% from 38%.
-
Cash Burn Cut 74%
Q3 cash usage was $2.4M versus $9.1M a year ago; cash stood at $77.4M against $40.0M of total debt as of September 30, 2026.
Analysis · SGHT · Industrial Applications And Services
The headline is a Q3 beat, but the guidance raise and dry-eye ramp matter more. Revenue of $24.9M grew 25% and cleared the $23.5M consensus, and management lifted full-year revenue guidance to $92M-$93M from $88M-$92M. The dry-eye franchise is the real change: TearCare revenue jumped to $3.9M from $0.2M a year ago, and FY26 IDE guidance went to roughly $12M from $9M-$11M. Cash burn fell 74% to $2.4M for the quarter, leaving $77.4M of cash against $40.0M of debt — a runway story improving at the same time growth accelerates.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 32.4% of the 2199 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SGHT was trading at $9.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $533.3M. The 52-week trading range was $3.38 to $10.06. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.